Virtual Medicinal Product (VMP) - Triptorelin embonate 22.5mg powder and solvent for prolonged-release suspension for injection vials

Navigation

Name Details

Name Start Date End Date
Name Current Name Triptorelin embonate 22.5mg powder and solvent for prolonged-release suspension for injection vials Start Date 01-01-2025 End Date
Previous Name Previous Name Triptorelin embonate 22.5mg powder and solvent for suspension for injection vials Start Date 15-11-2012 End Date 31-12-2024
Abbreviated Name Abbreviated Name Triptorelin embonate 22.5mg inj vials Start Date 15-11-2012
Previous Abbreviated Name Triptorelin embonate 28mg inj vials Previous Start Date 21-01-2011 Previous End Date 14-11-2012

Unit Dose & Form Information

DF Indicator
Discrete
UDFS Indicator
1.0
UDFS UOM
vial
Unit Dose UOM
vial

Summary

Prescribing Status
Valid as a prescribable product
Controlled Drug Category
No Controlled Drug Status
Route
Intramuscular
Form
Powder and solvent for prolonged-release suspension for inj
Ontology Form/Route
suspensioninjectionprolonged-release.intramuscular
Name Basis
INNM - International Non-proprietary Name (Modified)

Codes

ATC Code
L02AE04
BNF Codes
  • BNF code 08030402
SNOMED Codes
Code Start Date End Date
18496811000001106 21-01-2011

VMP Ingredients

VMP ingredients table
Name Basis of Strength Description BOSS Strength and UOM (Nmr) Strength and UOM (Dmr)
Triptorelin embonate Based on Base Substance Triptorelin 22.5 mg

Parent Products

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
1 vial 41400 Part VIIIA Category C